Q1 2025 Axon Enterprise Inc Earnings Call Transcript
Key Points
- Axon Enterprise Inc (AXON) reported a 31% year-over-year increase in first-quarter revenue, reaching $604 million, marking the 13th consecutive quarter with over 25% growth.
- The company achieved a 25.7% adjusted EBITDA margin and $1.1 billion in annual recurring revenue (ARR), reflecting strong financial performance.
- Axon Enterprise Inc (AXON) has seen rapid adoption of its TASER 10, with orders pacing at twice the rate of TASER 7, indicating strong market demand.
- International bookings are off to a strong start, with significant demand in regions such as Australia, Latin America, Canada, Asia, the UK, and Europe.
- The company has successfully diversified its supply chain to mitigate risks associated with tariffs and geopolitical uncertainties, ensuring better service to customers.
- The company faces potential impacts from tariffs, which are expected to affect the adjusted EBITDA margin by approximately 50 basis points for the full year.
- There are ongoing challenges with federal budget uncertainties, which could impact the volume of opportunities in the federal market.
- Axon Enterprise Inc (AXON) is still navigating hurdles related to its new headquarters project in Arizona, with some political opposition and obstacles remaining.
- The company is experiencing some supply constraints for its new fixed mobile hardware products, which may limit revenue impact this year.
- There is a risk of slower adoption of AI-related products in jurisdictions that are more skeptical of police technology, potentially affecting sales.
(audio in progress) business outlook and make forward-looking statements. Any forward-looking statements made today are pursuant to and within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These comments are based on our predictions and expectations as of today and are not guarantees of future performance. All forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially. We discuss these risks in our SEC filings.
We will also discuss certain non-GAAP financial measures. A description of each non-GAAP measure and a reconciliation of each non-GAAP measure to the most directly comparable GAAP measure can be found in our shareholder letter as well as on our Investor Relations website.
Now turning to our quarterly update. First, we're going to show you a quick video recapping some of our recent announcements from Axon Week in April.
(video playing)
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

